Search | ASTRO

SITC Advances in Cancer Immunotherapy (ACI) for Radiation Oncologists
Challenging Cases in the Management of Squamous Cell Carcinoma of the Skin
Clinical Applications of AI: Contouring and Patient-Specific QA
Pitfalls, Perils and Pearls: Identifying and Managing Gynecologic Treatment Toxicity
How Sentinel Lymph Node Biopsy is Impacting Adjuvant Radiation Treatment in Gynecologic Cancers
Hypofractionation for Soft Tissue Sarcoma
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
Practical Elements of a Radiopharmaceutical Program: Findings from ASTRO's Safety White Paper
Prophylactic Feeding Tube Placement in Head and Neck Cancer: Hard to Swallow?
Navigating Medical Insurance Delays and Denials: Insights from Patients, ASTRO and the Press
Head and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity in the Community Setting
Best Practices in the Management of Oligometastatic and Oligoprogressive Liver Metastases
Emerging Diagnostic and Therapeutic Options for Meningioma
ASTRO/JASTRO Joint Session: Advances in Liver Cancer Radiation Therapy
Red Journal Oncology Scans - 2024
Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment in a Community Setting
Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation
Management of Small Cell Neuroendocrine Tumors of the Genitourinary Tract
Implementation of a Prostate SBRT Program in the Community Setting
Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What Are the Limits?

Pages